Interpace Biosciences Stock Market Value
| IDXG Stock | USD 1.22 0.01 0.81% |
| Symbol | Interpace |
Interpace Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Interpace Biosciences' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Interpace Biosciences.
| 12/04/2025 |
| 01/03/2026 |
If you would invest 0.00 in Interpace Biosciences on December 4, 2025 and sell it all today you would earn a total of 0.00 from holding Interpace Biosciences or generate 0.0% return on investment in Interpace Biosciences over 30 days. Interpace Biosciences is related to or competes with LFTD Partners. Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating c... More
Interpace Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Interpace Biosciences' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Interpace Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.67 | |||
| Information Ratio | 0.0881 | |||
| Maximum Drawdown | 43.31 | |||
| Value At Risk | (10.45) | |||
| Potential Upside | 15.79 |
Interpace Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Interpace Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Interpace Biosciences' standard deviation. In reality, there are many statistical measures that can use Interpace Biosciences historical prices to predict the future Interpace Biosciences' volatility.| Risk Adjusted Performance | 0.0777 | |||
| Jensen Alpha | 0.6969 | |||
| Total Risk Alpha | 0.1261 | |||
| Sortino Ratio | 0.1004 | |||
| Treynor Ratio | 1.44 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Interpace Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Interpace Biosciences Backtested Returns
Interpace Biosciences appears to be abnormally volatile, given 3 months investment horizon. Interpace Biosciences holds Efficiency (Sharpe) Ratio of 0.12, which attests that the entity had a 0.12 % return per unit of risk over the last 3 months. By evaluating Interpace Biosciences' technical indicators, you can evaluate if the expected return of 0.88% is justified by implied risk. Please utilize Interpace Biosciences' Market Risk Adjusted Performance of 1.45, downside deviation of 6.67, and Risk Adjusted Performance of 0.0777 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Interpace Biosciences holds a performance score of 9. The company retains a Market Volatility (i.e., Beta) of 0.5, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Interpace Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Interpace Biosciences is expected to be smaller as well. Please check Interpace Biosciences' potential upside, as well as the relationship between the kurtosis and day typical price , to make a quick decision on whether Interpace Biosciences' current trending patterns will revert.
Auto-correlation | -0.36 |
Poor reverse predictability
Interpace Biosciences has poor reverse predictability. Overlapping area represents the amount of predictability between Interpace Biosciences time series from 4th of December 2025 to 19th of December 2025 and 19th of December 2025 to 3rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Interpace Biosciences price movement. The serial correlation of -0.36 indicates that just about 36.0% of current Interpace Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.36 | |
| Spearman Rank Test | -0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Interpace Biosciences lagged returns against current returns
Autocorrelation, which is Interpace Biosciences otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Interpace Biosciences' otc stock expected returns. We can calculate the autocorrelation of Interpace Biosciences returns to help us make a trade decision. For example, suppose you find that Interpace Biosciences has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Interpace Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Interpace Biosciences otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Interpace Biosciences otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Interpace Biosciences otc stock over time.
Current vs Lagged Prices |
| Timeline |
Interpace Biosciences Lagged Returns
When evaluating Interpace Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Interpace Biosciences otc stock have on its future price. Interpace Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Interpace Biosciences autocorrelation shows the relationship between Interpace Biosciences otc stock current value and its past values and can show if there is a momentum factor associated with investing in Interpace Biosciences.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Interpace OTC Stock
Interpace Biosciences financial ratios help investors to determine whether Interpace OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Interpace with respect to the benefits of owning Interpace Biosciences security.